University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Isentress

Isentress (raltegravir)

Type of Drug: Integrase Inhibitor
This is the first approved drug in a class of drugs called integrase inhibitors. It works by blocking an enzyme that the virus needs in order to make more virus. The enzyme that it blocks is called HIV integrase.
gray line
transparent gif

one 400 mg capsule, two times a day

  • Morning

    Isentress 400mg

    Isentress

  • Evening

    Isentress 400mg

    Isentress

Note: Isentress must be used with other anti-HIV medicines. It is intended for patients who are already taking or have taken anti-HIV medicines but whose medicines are not controlling their HIV infection.

Notes on taking this medication

  • Isentress interacts with certain tuberculosis medication. If you're being treated for TB or MAC, let your HIV provider know.

Side effects

  • Nausea; diarrhea; headache; muscle aches
  • Contact your doctor promptly if you experience unexplained muscle pain, tenderness, or weakness

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif

About | Site Map | Feedback | Subscribe | Donate | Disclaimer

UCSF - Center for HIV Information HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.